FIELD: medicine. SUBSTANCE: agent and a method of treatment of eye inflammatory diseases were proposed which involves administration of rapamycin by different routes at the doses 0.01-50 mg/kg body mass per 24 hr. EFFECT: improved method of treatment. 4 cl, 7 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION FOR LOCAL APPLICATION IN TREATING INFLAMMATORY EYE DISEASES AND METHOD FOR USING IT | 2012 |
|
RU2508123C1 |
| METHOD OF TREATING EYE DISEASES ACCOMPANIED BY OXIDATIVE STRESS | 2014 |
|
RU2577236C1 |
| COMPOUNDS FOR TREATING/PREVENTING INFLAMMATORY OPHTHALMIC DISEASES | 2011 |
|
RU2582609C2 |
| METHOD FOR TREATMENT OF INFLAMMATORY EYE DISEASES ASSOCIATED WITH AUTOIMMUNE PATHOLOGIES | 2016 |
|
RU2618167C1 |
| METHOD FOR DETERMINING THE NEED FOR PRESCRIBING ANTIBIOTIC THERAPY FOR UVEITIS | 2021 |
|
RU2762492C1 |
| METHOD OF INFLAMMATORY COMPLICATIONS FORECASTING WITHIN REPEATED EYE SURGICAL INTERVENTIONS | 2006 |
|
RU2330614C1 |
| 2,4-DISULFONYL-α-PHENYL-TERT-BUTYLNITRON, PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, FORM OF FREE ACID OR SALT FORM THEREOF, PHARMACEUTICAL COMPOSITIONS AND METHODS OF MEDICAL TREATMENT | 1994 |
|
RU2159231C2 |
| METHOD FOR TREATING INFLAMMATORY OPHTHALMIC DISEASES | 1999 |
|
RU2187984C2 |
| USE OF AGONISTS OF FORMYL PEPTIDE RECEPTOR 2 FOR TREATING INFLAMMATORY EYE DISEASES | 2014 |
|
RU2663911C2 |
| METHOD FOR TREATMENT OF UBEITIS OF OBSCURE AND VIRAL ETIOLOGY | 2005 |
|
RU2301672C1 |
